AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $3.7M invested in Akari Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

26% less capital invested

Capital invested by funds: $5.03M → $3.7M (-$1.32M)

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$171K
2
+$36K
3
+$34.4K
4
HighTower Advisors
HighTower Advisors
Illinois
+$25K
5
Bank of America
Bank of America
North Carolina
+$5K

Top Sellers

1
-$699K
2
-$266K
3
-$15K
4
TC
Truvestments Capital
Florida
-$527
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.56M
2
$773K
3
$232K
4
$53K
5
$36K
6
$25K
7
$6K
8
$5K
9
$4K
10
$2K
11
–
12
–
13
–